103 related articles for article (PubMed ID: 38723736)
1. Elevated extracellular vesicular Nm23-H1 subdues the pro-migratory potential of breast cancer cell-derived extracellular vesicles.
Saini V; Do Y; Yam JWP; Wong YH
Cell Signal; 2024 May; 120():111203. PubMed ID: 38723736
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
Ouatas T; Halverson D; Steeg PS
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
[TBL] [Abstract][Full Text] [Related]
3. Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells.
Salerno M; Palmieri D; Bouadis A; Halverson D; Steeg PS
Mol Cell Biol; 2005 Feb; 25(4):1379-88. PubMed ID: 15684389
[TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor peptide SA12 inhibits metastasis of MDA-MB-231 and MCF-7 breast cancer cells via increasing expression of the tumor metastasis suppressor genes, CDH1, nm23-H1 and BRMS1.
Yang L; Lin F; Gao Z; Chen X; Zhang H; Dong K
Exp Ther Med; 2020 Aug; 20(2):1758-1763. PubMed ID: 32742405
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.
Campos A; Salomon C; Bustos R; Díaz J; Martínez S; Silva V; Reyes C; Díaz-Valdivia N; Varas-Godoy M; Lobos-González L; Quest AF
Nanomedicine (Lond); 2018 Oct; 13(20):2597-2609. PubMed ID: 30338706
[TBL] [Abstract][Full Text] [Related]
7. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential.
Myeroff LL; Markowitz SD
J Natl Cancer Inst; 1993 Jan; 85(2):147-52. PubMed ID: 8418304
[TBL] [Abstract][Full Text] [Related]
8. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.
Howlett AR; Petersen OW; Steeg PS; Bissell MJ
J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158
[TBL] [Abstract][Full Text] [Related]
9. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract][Full Text] [Related]
10. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM
Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005
[TBL] [Abstract][Full Text] [Related]
12. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
[TBL] [Abstract][Full Text] [Related]
13. Mutations at the dimer interface and surface residues of Nm23-H1 metastasis suppressor affect its expression and function.
Li Y; Liu W; Saini V; Wong YH
Mol Cell Biochem; 2020 Nov; 474(1-2):95-112. PubMed ID: 32705629
[TBL] [Abstract][Full Text] [Related]
14. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
[TBL] [Abstract][Full Text] [Related]
15. Clinical-translational approaches to the Nm23-H1 metastasis suppressor.
Steeg PS; Horak CE; Miller KD
Clin Cancer Res; 2008 Aug; 14(16):5006-12. PubMed ID: 18698018
[TBL] [Abstract][Full Text] [Related]
16. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.
Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS
J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213
[TBL] [Abstract][Full Text] [Related]
17. Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.
McDermott WG; Boissan M; Lacombe ML; Steeg PS; Horak CE
Clin Exp Metastasis; 2008; 25(2):131-8. PubMed ID: 18058029
[TBL] [Abstract][Full Text] [Related]
18. Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue.
Andolfo I; De Martino D; Liguori L; Petrosino G; Troncone G; Tata N; Galasso A; Roma C; Chiancone F; Zarrilli S; Arrigoni G; Staibano S; Imbimbo C; Zollo M
Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):489-98. PubMed ID: 21553004
[TBL] [Abstract][Full Text] [Related]
19. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
20. Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma.
Wang YF; Chen JY; Chang SY; Chiu JH; Li WY; Chu PY; Tai SK; Wang LS
Int J Cancer; 2008 Jan; 122(2):377-86. PubMed ID: 17918157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
